Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity

RM Catalioto, AR Renzetti, M Criscuoli, J Mizrahi… - European journal of …, 1994 - Elsevier
RM Catalioto, AR Renzetti, M Criscuoli, J Mizrahi, A Subissi
European journal of pharmacology, 1994Elsevier
Angiotensin II and angiotensin III stimulated protacylin release in a time-and dose-
dependent manner in both the prostatic and the non-prostatic part of the rabbit vas deferens.
Also, angiotensin I enhanced the production of prostacyclin and its effect was blocked by
captopril. Losartan, a type 1 (angiotensin AT 1)-selective receptor antagonist, prevented the
angiotensin II-induced prostacyclin release. The agonist peptide, p-aminphenylalanine 6
angiotensin II, and the type 2 (angiotensin AT 2)-selective receptor antagonist, PD123319 …
Abstract
Angiotensin II and angiotensin III stimulated protacylin release in a time- and dose- dependent manner in both the prostatic and the non-prostatic part of the rabbit vas deferens. Also, angiotensin I enhanced the production of prostacyclin and its effect was blocked by captopril. Losartan, a type 1 (angiotensin AT1)-selective receptor antagonist, prevented the angiotensin II-induced prostacyclin release. The agonist peptide, p-aminphenylalanine6 angiotensin II, and the type 2 (angiotensin AT2)-selective receptor antagonist, PD123319, were found active only in the prostatic portion, suggesting heterogeneity of the receptor population. In conclusion, an angiotensin AT1 receptor mostly mediates the angiotensin-induced release of prostacyclin in the rabbit vas deferens.
Elsevier